Introducing: Flyrcado™
GE HealthCare marks the U.S. launch of flurpiridaz F 18 – a radiopharmaceutical used in PET to evaluate for myocardial ischemia and infarction in known or suspected coronary artery disease patients. *See ISI below
Introducing: Flyrcado™
GE HealthCare marks the U.S. launch of flurpiridaz F 18 – a radiopharmaceutical used in PET to evaluate for myocardial ischemia and infarction in known or suspected coronary artery disease patients. *See ISI below